Gepke Visser

6.3k citations

109 papers · 3.6k indexed · h-index 30

Co-authors: James V. Leonard Kurt Ullrich Philippe Labrune Jan Peter Rake Gerrit Smit Ronald J. A. Wanders Frits A. Wijburg Peter Smit
Topics: Metabolism and Genetic Disorders (62 papers)Glycogen Storage Diseases and Myoclonus (23 papers)Mitochondrial Function and Pathology (21 papers)
Cited by: Clinical Biochemistry Rheumatology Pharmacy
Journals: Blood PLoS ONE American Journal of Clinical Nutrition
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Gepke Visser

107 papers receiving 3.5k citations

Peers

Countries citing papers authored by Gepke Visser

Since Specialization

Citations

This map shows the geographic impact of Gepke Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gepke Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gepke Visser more than expected).

Fields of papers citing papers by Gepke Visser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gepke Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gepke Visser. The network helps show where Gepke Visser may publish in the future.

Co-authorship network of co-authors of Gepke Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Gepke Visser. A scholar is included among the top collaborators of Gepke Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gepke Visser. Gepke Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study 2025 ·Blood Advances ·Cédric Pastoret,Jun Yang,David J. Feith,Mikaël Roussel,Aline Moignet,(unknown),Michael D. Solga,Tony Marchand,Gepke Visser,Vanessa Rebecca Gasparini,Antonella Teramo,Renato Zambello,Thomas P. Loughran,T. Lamy	0
2	A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child 2023 ·Orphanet Journal of Rare Diseases ·(unknown),(unknown),Tessa van Dijk,(unknown),Gepke Visser,Mirjam Langeveld,Lidewij Henneman	1
3	Newborn screening for primary carnitine deficiency: who will benefit? – a retrospective cohort study 2023 ·Journal of Medical Genetics ·(unknown),Sacha Ferdinandusse,Saskia N. van der Crabben,Eugènie Dekkers,Sabine A. Fuchs,Hidde H. Huidekoper,Mirian C. H. Janssen,Janneke G. Langendonk,(unknown),(unknown),(unknown),Francjan J. van Spronsen,Frédéric M. Vaz,(unknown),Maaike de Vries,Frits A. Wijburg,Gepke Visser,Mirjam Langeveld	7
4	Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation 2021 ·Frontiers in Pharmacology ·Arie O. Verkerk,Suzan J. G. Knottnerus,Vincent Portero,Jeannette C. Bleeker,Sacha Ferdinandusse,Kaomei Guan,Lodewijk IJlst,Gepke Visser,Ronald J. A. Wanders,Frits A. Wijburg,Connie R. Bezzina,Isabella Mengarelli,Riekelt H. Houtkooper	7
5	Exploring the metabolic fate of medium-chain triglycerides in healthy individuals using a stable isotope tracer 2020 ·Clinical Nutrition ·Suzan J. G. Knottnerus,(unknown),Henk Schierbeek,Jeannette C. Bleeker,(unknown),Sacha Ferdinandusse,Johannes B. van Goudoever,Riekelt H. Houtkooper,Lodewijk IJlst,Mirjam Langeveld,Ronald J. A. Wanders,Frédéric M. Vaz,Frits A. Wijburg,Gepke Visser	11
6	Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates 2020 ·International Journal of Molecular Sciences ·Suzan J. G. Knottnerus,Isabella Mengarelli,Rob C. I. Wüst,Antonius Baartscheer,Jeannette C. Bleeker,Ruben Coronel,Sacha Ferdinandusse,Kaomei Guan,Lodewijk IJlst,(unknown),Xiaojing Luo,Vincent Portero,(unknown),Gepke Visser,Ronald J. A. Wanders,Frits A. Wijburg,Arie O. Verkerk,Riekelt H. Houtkooper,Connie R. Bezzina	24
7	Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I 2020 ·Journal of Clinical Medicine ·Rosario Mosca,Diantha van de Vlekkert,Yvan Campos,(unknown),(unknown),(unknown),Emil Kakkis,Cynthia J. Tifft,Camilo Toro,(unknown),Cinzia Gellera,Laura Canafoglia,Gepke Visser,Ida Annunziata,Alessandra d’Azzo	15
8	A nationwide retrospective observational study of population newborn screening for medium‐chain acyl‐CoA dehydrogenase (MCAD) deficiency in the Netherlands 2019 ·Journal of Inherited Metabolic Disease ·(unknown),(unknown),Annet M. Bosch,Margot F. Mulder,M. Estela Rubio‐Gozalbo,Gepke Visser,Maaike de Vries,Monique Williams,Hans R. Waterham,Francjan J. van Spronsen,Peter C. J. I. Schielen,Terry G. J. Derks	22
9	Mutated PET117 causes complex IV deficiency and is associated with neurodevelopmental regression and medulla oblongata lesions 2017 ·Human Genetics ·G. Herma Renkema,Gepke Visser,Fabian Baertling,Liesbeth T. Wintjes,Victorien M. Wolters,Joris van Montfrans,G.A.P. de Kort,Peter G. J. Nikkels,Peter M. van Hasselt,Saskia N. van der Crabben,Richard J. Rodenburg	27
10	Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability 2016 ·Genetics in Medicine ·Glen R. Monroe,G. W. J. Frederix,Sanne M. C. Savelberg,Tamar I. de Vries,Karen Duran,Jasper J. van der Smagt,Pauline Terhal,Peter M. van Hasselt,Hester Y. Kroes,Nanda M. Verhoeven‐Duif,Isaäc J. Nijman,Ellen C. Carbo,Koen L.I. van Gassen,Nine Knoers,Anke M. Hövels,Mieke M. van Haelst,Gepke Visser,Gijs van Haaften	125
11	A New Approach for Fast Metabolic Diagnostics in CMAMMA 2016 ·JIMD Reports ·Monique G.M. de Sain–van der Velden,Maria van der Ham,Judith Jans,Gepke Visser,Hubertus C.M.T. Prinsen,Nanda M. Verhoeven‐Duif,Koen L.I. van Gassen,Peter M. van Hasselt	5
12	Occurrence of subdural hematomas in Dutch glutaric aciduria type 1 patients 2016 ·European Journal of Pediatrics ·(unknown),Gepke Visser,Frits A. Wijburg,Francjan J. van Spronsen,Monique Williams,Rick R. van Rijn	15
13	Hereditaire fructose-intolerantie 2014 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·(unknown),Hans R. Waterham,(unknown),Peter M. van Hasselt,Gepke Visser	1
14	Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study 2012 ·Orphanet Journal of Rare Diseases ·(unknown),Gerrit Smit,Maaike de Vries,Johannis B.C. de Klerk,Annet M. Bosch,Gepke Visser,Margot F. Mulder,M. Estela Rubio‐Gozalbo,Bert Elvers,Klary E. Niezen‐Koning,Ronald J. A. Wanders,Hans R. Waterham,Dirk‐Jan Reijngoud,Terry G. J. Derks	24
15	A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11β gene 2012 ·Journal of Medical Genetics ·Merel S. Ebberink,Janet Koster,Gepke Visser,Francjan van Spronsen,Irene Stolte‐Dijkstra,Gerrit Smit,Johanna M. Fock,Stephan Kemp,Ronald J. A. Wanders,Hans R. Waterham	98
16	The clinical utility of MRI in patients with neurodevelopmental disorders of unknown origin 2010 ·European Journal of Neurology ·(unknown),Rutger A. J. Nievelstein,R. H. J. M. Gooskens,Hester Y. Kroes,R. van Empelen,Olga Braams,D. Wittebol‐Post,Margriet M. W. B. Hendriks,Gepke Visser	7
17	Yield of additional metabolic studies in neurodevelopmental disorders 2008 ·Annals of Neurology ·(unknown),Ruud Berger,Peter van Hasselt,(unknown),Monique G.M. de Sain–van der Velden,Hester Y. Kroes,Gepke Visser	26
18	Identification of a novel mutation (867delA) in the glucose-6-phosphatase gene in two siblings with glycogen storage disease type Ia with different phenotypes 2000 ·Human Mutation ·Jan Peter Rake,(unknown),Gepke Visser,Edwin Verlind,Klary E. Niezen‐Koning,Charles H.C.M. Buys,G. P. A. Smit,Hans Scheffer	10
19	A Convenient Diagnostic Function Test of Peripheral Blood Neutrophils in Glycogen Storage Disease Type Ib 1999 ·Pediatric Research ·Arthur J. Verhoeven,Gepke Visser,Rob van Zwieten,Beata Gruszczyńska,(unknown),Gerrit Smit	21
20	Succinyl-CoA:acetoacetate transferase deficiency: identification of a new patient with a neonatal onset and review of the literature 1997 ·European Journal of Pediatrics ·Klary E. Niezen‐Koning,Ronald J. A. Wanders,Jos P.N. Ruiter,Lodewijk IJlst,Gepke Visser,(unknown),H. S. A. Heymans,Dirk‐Jan Reijngoud,Gerrit Smit	28

About Gepke Visser

Gepke Visser is a scholar working on Clinical Biochemistry, Rheumatology and Physiology, having authored 109 papers that have together received 3.6k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (62 papers), Glycogen Storage Diseases and Myoclonus (23 papers) and Mitochondrial Function and Pathology (21 papers). The work is most often cited by research in Clinical Biochemistry (1.2k citations), Rheumatology (1.5k citations) and Pharmacy (207 citations). Gepke Visser has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include James V. Leonard, Kurt Ullrich, Philippe Labrune, Jan Peter Rake, Gerrit Smit, Ronald J. A. Wanders, Frits A. Wijburg, Peter Smit, Monique G.M. de Sain–van der Velden and Peter M. van Hasselt. Their work appears in journals such as Blood, PLoS ONE and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact